{"brief_title": "Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)", "brief_summary": "A clinical study to determine the efficacy and safety of MK0869 in the treatment of depression", "detailed_description": "The duration of treatment is 8 weeks.", "condition": ["Major Depressive Disorder"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["MK0869, aprepitant", "Comparator: paroxetine HCL"], "criteria": "Major Depressive Disorder", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Disease", "Depressive Disorder", "Depression", "Depressive Disorder, Major", "Aprepitant", "Fosaprepitant", "Paroxetine"], "id": "NCT00035009"}